相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic landscape of papillary thyroid carcinoma in the Chinese population
Jialong Liang et al.
JOURNAL OF PATHOLOGY (2018)
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
Alanna J. Church et al.
MODERN PATHOLOGY (2018)
Infantile NTRK-associated Mesenchymal Tumors
Jessica L. Davis et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2018)
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study
Christian Vokuhl et al.
PEDIATRIC BLOOD & CANCER (2018)
Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors
Erin R. Rudzinski et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
Gregory P. Kalemkerian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
Sherise D. Ferguson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
An active drug for TRK-positive paediatric solid tumours
Lucas Moreno
LANCET ONCOLOGY (2018)
Novel TLE4-NTRK2 fusion in a ganglioglioma identified by array-CGH and confirmed by NGS: Potential for a gene targeted therapy
Nitya Prabhakaran et al.
NEUROPATHOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Julie George et al.
NATURE COMMUNICATIONS (2018)
Tyrosine receptor kinase B is a drug target in astrocytomas
Jing Ni et al.
NEURO-ONCOLOGY (2017)
Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms
Lu Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer
Darren Sigal et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Alison M. Schram et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication
Steven Lemery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children
Maria Isabel C. Vieira Cordioli et al.
THYROID (2017)
Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima
Keita Iyama et al.
THYROID (2017)
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon et al.
CANCER DISCOVERY (2017)
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon et al.
CANCER DISCOVERY (2017)
Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient
Massimo Milione et al.
ONCOTARGET (2017)
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions
Jaclyn F. Hechtman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis
Ryan J. Hartmaier et al.
CANCER RESEARCH (2017)
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra
Juliann Chmielecki et al.
CANCER RESEARCH (2017)
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib
Victor Wong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
Andrea Sartore-Bianchi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib
Victor Wong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
Andrea Sartore-Bianchi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?
K. M. Kerr et al.
ANNALS OF ONCOLOGY (2016)
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
A. Drilon et al.
ANNALS OF ONCOLOGY (2016)
NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States
Manju L. Prasad et al.
CANCER (2016)
Clinical safety and activity from a phase I study of LOX0-101, a selective TR A B/C inhibitor, in solid-tumor patients with NTRK gene fusions
David S. Hong et al.
CANCER RESEARCH (2016)
A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing
Carol Beadling et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
FGFR1 and NTRK3 actionable alterations in Wild-Type gastrointestinal stromal tumors
Eileen Shi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
Elena Ardini et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M. Ali et al.
ONCOLOGIST (2016)
Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement
Dina El Demellawy et al.
PATHOLOGY (2016)
Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101
Ramamoorthy Nagasubramanian et al.
PEDIATRIC BLOOD & CANCER (2016)
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Lukas Bubendorf et al.
VIRCHOWS ARCHIV (2016)
Identifying fusion transcripts using next generation sequencing
Shailesh Kumar et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)
Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma
Laurent Creancier et al.
CANCER LETTERS (2015)
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
Alexander Drilon et al.
CLINICAL CANCER RESEARCH (2015)
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F. Farago et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
Marina Pekar-Zlotin et al.
ONCOLOGIST (2015)
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
Robert C. Doebele et al.
CANCER DISCOVERY (2015)
Mammary Analogue Secretory Carcinoma of Salivary Glands
Alena Skálová et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
The landscape and therapeutic relevance of cancer-associated transcript fusions
K. Yoshihara et al.
ONCOGENE (2015)
TRKing Down an Old Oncogene in a New Era of Targeted Therapy
Aria Vaishnavi et al.
CANCER DISCOVERY (2015)
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
Elena Ardini et al.
MOLECULAR ONCOLOGY (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Anchored multiplex FOR for targeted next-generation sequencing
Zongli Zheng et al.
NATURE MEDICINE (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
Jeffrey S. Ross et al.
ONCOLOGIST (2014)
NTRK1 Fusion in Glioblastoma Multiforme
Jinkuk Kim et al.
PLOS ONE (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
David T. W. Jones et al.
NATURE GENETICS (2013)
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
Aria Vaishnavi et al.
NATURE MEDICINE (2013)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Frequent mutations in the neurotrophic tyrosine receptor kinase, gene family in large cell neuroendocrine carcinoma of the lung
Antonio Marchetti et al.
HUMAN MUTATION (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Neuratrophin-regulated signalling pathways
Louis F. Reichardt
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population
Ewa Brzezianska et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors
JM Bourgeois et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
